The Nikkei Medical Online Prescription Drug Dictionary reportedly includes basic information and package insert details for Rinolosaal Ophthalmic and Otic Solution 0.1%.
The basic information on Rinolosaal Ophthalmic and Otic Solution 0.1% describes it as a drug whose anti-inflammatory and antiallergic effects relieve ophthalmic inflammatory conditions such as blepharitis, conjunctivitis and keratitis, as well as eye inflammation after surgery.
The package insert distinguishes between ophthalmic and otolaryngological indications. For ophthalmic use, it is primarily a symptomatic treatment administered into the conjunctival sac. For otolaryngological use, it is indicated for inflammatory and allergic conditions of the external and middle ear and upper respiratory tract.
The dosage section states that, for ophthalmic use, 1 to 2 drops should be instilled 3 to 4 times a day. For otolaryngological use, an appropriate amount should be used 1 to several times a day for ear drops, nasal drops, ear irrigation, nebulization or similar applications. Serious adverse reactions include glaucoma, corneal herpes and ocular perforation, and monitoring is considered necessary.
Patients with a history of hypersensitivity to the ingredients are listed as contraindicated. The information also notes the possibility of systemic effects during long-term or high-dose administration, along with specific precautions for pregnant women, children and older adults.